Abbott stent superior to Boston Sci after 3 years: study (Reuters)
Sunday, March 29th, 2009Reuters – Safety advantages of Abbott Laboratories' Xience stent over Boston Scientific Corp's rival Taxus stent increased between two and three years, according to long-term data presented on Sunday.